Variation in factor B (BF) and complement component 2 (C2) genes is associated with age-related macular degeneration
Open accessThe DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
Abstract
Age-related macular degeneration (AMD) is the most common form of irreversible blindness in developed countries. Variants in the factor H gene (CFH, also known as HF1), which encodes a major inhibitor of the alternative complement pathway, are associated with the risk for developing AMD. Here we test the hypothesis that variation in genes encoding other regulatory proteins of the same pathway is associated with AMD. We screened factor B (BF) and complement component 2 (C2) genes, located in the major histocompatibility complex class III region, for genetic variation in two independent cohorts comprising approximately 900 individuals with AMD and approximately 400 matched controls. Haplotype analyses identify a statistically significant common risk haplotype (H1) and two protective haplotypes. The L9H variant of BF and the E318D variant of C2 (H10), as well as a variant in intron 10 of C2 and the R32Q variant of BF (H7), confer a significantly reduced risk of AMD (odds ratio = 0.45 and 0.36, respectively). Combined analysis of the C2 and BF haplotypes and CFH variants shows that variation in the two loci can predict the clinical outcome in 74% of the affected individuals and 56% of the controls. These data expand and refine our understanding of the genetic risk for AMD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“This analysis resulted in the identification of the previously well documented independently associated variants near CFH and C2/CFB8,10,31,32 and of additional independent signals near C3, CETP, LIPC, FRK/COL10A1, IER3/DDR1, RAD51B (Supplementary Table 6).”
From Seven new loci associated with age-related macular degeneration (2013) · cites this paper as [8]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Genes in the complement pathway4–11 and a region of chromosome 10 12,13 have now been implicated as the major genetic contributors to disease.”
From Seven new loci associated with age-related macular degeneration (2013) · cites this paper as [8]
The cited source says what the claim attributes to it.
In the citing paper
“These include complement 2 (C2) and/or complement factor B (CFB) (56), complement 3 (C3) (170), and complement factor I (CFI) (44).”
From Unraveling a Multifactorial Late-Onset Disease: From Genetic Susceptibility to Disease Mechanisms for Age-Related Macular Degeneration (2009) · cites this paper as [56]
In the citing paper
“studies have demonstrated that at least one of the two variants associated with AMD—R32Q BF—leads to an impairment in the complement activating function of BF (Gold et al., 2006).”
From Molecular pathology of age-related macular degeneration (2009) · cites this paper as Gold et al., 2006
In the citing paper
“the L9H BF/E318D C2 and R32Q BF/intronic variants of C2 have been shown to be protective for AMD (odds ratio (OR) = 0.45 and 0.36, respectively) by Gold et al.”
From Molecular pathology of age-related macular degeneration (2009) · cites this paper as Gold et al., 2006
1 more claim about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Controlling the False Discovery Rate: A Practical and Powerful Approach to Multiple Testing
Benjamini, Y., & Hochberg, Y. (1995) · Journal of the Royal Statistical Society Series B: Statistical Methodology · doi:10.1111/j.2517-6161.1995.tb02031.x · Cited by 109,482 · cited 1×
“Overall type I error rates (α) were retrospectively calculated using a previously described metho”
MethodComplement factor H polymorphism in age-related macular degeneration
Klein, R. J., Zeiss, C., Chew, E. Y., Tsai, J.-Y., Sackler, R. S., Haynes, C., Henning, A. K., SanGiovanni, J. P., Mane, S. M., Mayne, S. T., et al. (2005) · Science · doi:10.1126/science.1109557 · Cited by 4,492
Complement factor H polymorphism and age-related macular degeneration
Edwards, A. O., Ritter, R., Abel, K. J., Manning, A., Panhuysen, C., & Farrer, L. A. (2005) · Science · doi:10.1126/science.1110189 · Cited by 2,449
Complement factor H variant increases the risk of age-related macular degeneration
Haines, J. L., Hauser, M. A., Schmidt, S., Scott, W. K., Olson, L. M., Gallins, P., Spencer, K. L., Kwan, S. Y., Noureddine, M., Gilbert, J. R., et al. (2005) · Science · doi:10.1126/science.1110359 · Cited by 2,424
Hageman, G. S., Anderson, D. H., Johnson, L. V., Hancox, L. S., Taiber, A. J., Hardisty, L. I., Hageman, J. L., Stockman, H. A., Borchardt, J. D., Gehrs, K. M., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0501536102 · Cited by 1,961
Self-citationBird, A. C., Bressler, N. M., Bressler, S. B., Chisholm, I. H., Coscas, G., Davis, M. D., de Jong, P. T. V. M., Klaver, C. C. W., Klein, B. E. K., Klein, R., et al. (1995) · Survey of Ophthalmology · doi:10.1016/s0039-6257(05)80092-x · Cited by 1,926
Hageman, G. (2001) · Progress in Retinal and Eye Research · doi:10.1016/s1350-9462(01)00010-6 · Cited by 1,265
Self-citationDrusen proteome analysis: an approach to the etiology of age-related macular degeneration
Crabb, J. W., Miyagi, M., Gu, X., Shadrach, K., West, K. A., Sakaguchi, H., Kamei, M., Hasan, A., Yan, L., Rayborn, M. E., et al. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.222551899 · Cited by 1,208
A Fine-Scale Map of Recombination Rates and Hotspots Across the Human Genome
Myers, S., Bottolo, L., Freeman, C., McVean, G., & Donnelly, P. (2005) · Science · doi:10.1126/science.1117196 · Cited by 1,134 · cited 1×
“Fourth, estimated recombination rates from HapMap data indicate regions of high recombination on both sides of the C2/BF locu”
BackgroundA role for local inflammation in the formation of drusen in the aging eye
Anderson, D. H., Mullins, R. F., Hageman, G. S., & Johnson, L. V. (2002) · American Journal of Ophthalmology · doi:10.1016/s0002-9394(02)01624-0 · Cited by 1,087
Self-citation
Cited by
Items 601–700 of 1,000
Fanelli, G., Gonzalez-Cordero, A., Gardner, P. J., Peng, Q., Fernando, M., Kloc, M., Farrar, C. A., Naeem, A., Garred, P., Ali, R. R., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-15212-z · Cited by 23
A model to study complement involvement in experimental retinal degeneration
Mohlin, C., Sandholm, K., Kvanta, A., Ekdahl, K. N., & Johansson, K. U. I. (2018) · Upsala Journal of Medical Sciences · doi:10.1080/03009734.2018.1431744 · Cited by 22
Schnabolk, G., Rohrer, B., & Simpson, K. N. (2019) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.18-26444 · Cited by 22
Syndrome hémolytique et urémique lié à des anomalies du complément
Frémeaux‐Bacchi, V., Fakhouri, F., Roumenina, L. T., Dragon‐Durey, M., & Loirat, C. (2011) · La Revue de Médecine Interne · doi:10.1016/j.revmed.2009.09.039 · Cited by 22
Epidemiology of Age-related Macular Degeneration
Seddon, J. M., & Sobrin, L. (2008) · Elsevier eBooks · doi:10.1016/b978-1-4160-0016-7.50041-2 · Cited by 29
Bok, D. (2007) · Archives of Ophthalmology · doi:10.1001/archopht.125.2.160 · Cited by 22
Genetic Ophthalmology and the Era of Clinical Care
Sieving, P. A., & Collins, F. S. (2007) · JAMA · doi:10.1001/jama.297.7.733 · Cited by 22
Human genetic variations: Beacons on the pathways to successful ageing
Cluett, C., & Melzer, D. R. (2009) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2009.06.009 · Cited by 24
“This highlighted an association with variants within the 6p21 MHC region (Gold et al., 2006; Maller et al., 2006).”
Highly Penetrant Alleles in Age-Related Macular Degeneration
den Hollander, A. I., & de Jong, E. K. (2014) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a017202 · Cited by 23
“In addition, several genetic variants with smaller effect sizes have been identified in other complement factor genes (CFB/C2, C3, and CFI) (Gold et al. 2006; Yates et al. 2007; Fagerness et al. 2009) as well as in genes encoding members of the high-density lipoprotein cholesterol pathway Editors: Eric A. Pierce, Rich…”
BackgroundInfluentialFan, X., Hovinga, J. A. K., Shirotani-Ikejima, H., Eura, Y., Hirai, H., Honda, S., Kokame, K., Taleghani, M. M., von Krogh, A.-S., Yoshida, Y., et al. (2016) · International Journal of Hematology · doi:10.1007/s12185-015-1933-7 · Cited by 21
“L9H within the CFB signal peptide sequence has been reported to be protective for age-related macular degeneration [22].”
BackgroundDirect-to-Consumer Personal Genome Testing for Age-Related Macular Degeneration
Buitendijk, G. H. S., Amin, N., Hofman, A., van Duijn, C. M., Vingerling, J. R., & Klaver, C. C. W. (2014) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.14-15142 · Cited by 22
ATM Gene Variants in Patients with Idiopathic Perifoveal Telangiectasia
BARBAZETTO, I. A., Room, M., Yannuzzi, N. A., Barile, G. R., Merriam, J. E., Bardal, A. M. C., Freund, K. B., Yannuzzi, L. A., & Allikmets, R. L. (2008) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.07-1357 · Cited by 21
Self-citationAgbeko, R., Fidler, K., Allen, M. L., Wilson, P., Klein, N. J., & Peters, M. J. (2010) · Pediatric Critical Care Medicine · doi:10.1097/pcc.0b013e3181d900ba · Cited by 21
“In addition, new data on AMD show that CFB L9H may not modify risk (44, 45).”
BackgroundInfluentialRohrer, B., Demos, C., Frigg, R., & Grimm, C. (2006) · Experimental Eye Research · doi:10.1016/j.exer.2006.08.017 · Cited by 21
“Based on these results, it has been proposed that inadequate control of complement-driven immune-response may be an important factor in the pathogenesis of AMD.”
BackgroundInfluentialPoppelaars, F., Holers, V. M., & Thurman, J. M. (2025) · Journal of Clinical Investigation · doi:10.1172/jci188347 · Cited by 20
“Later research uncovered variants in additional complement genes that contributed to disease risk (12, 247, 248), partic-NMOSD, eculizumab reduced the relative relapse risk by 94% compared with placebo (175).”
Association of LIPC and advanced age-related macular degeneration
Lee, J., Zeng, J., Hughes, G., Chen, Y., Grob, S., Zhao, L., Lee, C., Krupa, M., Quach, J., Luo, J., et al. (2013) · Eye · doi:10.1038/eye.2012.276 · Cited by 20
CETP Gene may be Associated with Advanced Age-Related Macular Degeneration in the Chinese Population
Wang, D., Zhou, J., Hou, X., Nguyen, D. H., Cao, G., Li, G., Qiu, G., Zhang, K., Zhang, M., & Su, Z. (2014) · Ophthalmic Genetics · doi:10.3109/13816810.2014.881506 · Cited by 21
Pluripotent Stem Cells to Model Degenerative Retinal Diseases: The RPE Perspective
Dalvi, S., Galloway, C. A., & Singh, R. (2019) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-28471-8_1 · Cited by 21
Yasukawa, T., Wiedemann, P., Hoffmann, S. R. K., Kacza, J., Eichler, W., Wang, Y., Nishiwaki, A., Seeger, J., & Ogura, Y. (2007) · Graefe s Archive for Clinical and Experimental Ophthalmology · doi:10.1007/s00417-007-0571-z · Cited by 21
Shen, Y., Zhang, J., Xu, X., Fu, J., Liu, F., & Li, J. (2012) · Fish & Shellfish Immunology · doi:10.1016/j.fsi.2012.01.032 · Cited by 20
Ma, K. N., Cashman, S. M., Sweigard, J. H., & Kumar-Singh, R. (2010) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.10-5887 · Cited by 19
Pseudo-Vitelliform Macular Detachment and Cuticular Drusen: Exclusion of 6 Candidate Genes
BARBAZETTO, I. A., Yannuzzi, N. A., Klais, C. M. C., Merriam, J. E., Zernant, J., Peiretti, E., Yannuzzi, L. A., & Allikmets, R. L. (2007) · Ophthalmic Genetics · doi:10.1080/13816810701538596 · Cited by 20
Self-citationComplement Factor B Polymorphism and the Phenotype of Early Age-related Macular Degeneration
Mantel, I., Ambresin, A., Moetteli, L., Droz, I., Roduit, R., Munier, F. L., & Schorderet, D. F. (2013) · Ophthalmic Genetics · doi:10.3109/13816810.2013.766217 · Cited by 20
“However, the present data still gives important insight into the phenotype–genotype correlation of early AMD.”
InfluentialYanagisawa, S., Kondo, N., Miki, A., Matsumiya, W., Kusuhara, S., Tsukahara, Y., Honda, S., & Negi, A. (2011) · PubMed Central · Cited by 21
Contreras, A. V., Zenteno, J. C., Fernández-López, J. C., Rodríguez-Corona, U., Falfán‐Valencia, R., Sebastián-Medina, L., Morales, F., Ochoa‐Contreras, D., Carnevale, A., & Silva‐Zolezzi, I. (2014) · PubMed Central · Cited by 24
Demos, C., Bandyopadhyay, M., & Rohrer, B. (2008) · PubMed Central · Cited by 22
Sitnilska, V., Enders, P., Cursiefen, C., Fauser, S., & Altay, L. (2020) · Graefe s Archive for Clinical and Experimental Ophthalmology · doi:10.1007/s00417-020-04910-6 · Cited by 20
Association of paired box 6 with high myopia in Japanese.
Miyake, M., Yamashiro, K., Nakanishi, H., Nakata, I., Akagi-Kurashige, Y., Tsujikawa, A., Moriyama, M., Ohno‐Matsui, K., Mochizuki, M., Yamada, R., et al. (2012) · PubMed Central · Cited by 19
Chavali, V. R. M., Diniz, B. C., Huang, J., Ying, G., Sadda, S. R., & Stambolian, D. (2015) · Journal of Clinical Medicine · doi:10.3390/jcm4020304 · Cited by 19
“Apart from CFH and SYN3, the other genotyped genes, ARMS2, C3, CFB, LIPC, CETP and CFI genes, were not associated with our drusen phenotypes.”
BackgroundInfluentialGenome-wide association studies: applications and insights gained in Ophthalmology
Chandra, A., Mitry, D., Wright, A. F., Campbell, H. J., & Charteris, D. G. (2014) · Eye · doi:10.1038/eye.2014.145 · Cited by 21
Hollborn, M., Ackmann, C., Kuhrt, H., Doktor, F., Kohen, L., Wiedemann, P., & Bringmann, A. (2018) · PubMed Central · Cited by 21
Short-Term Changes of Basal Laminar Drusen on Spectral-Domain Optical Coherence Tomography
van de Ven, J. P., Boon, C. J. F., Smailhodzic, D., Lechanteur, Y. T. E., den Hollander, A. I., Hoyng, C. B., & Theelen, T. (2012) · American Journal of Ophthalmology · doi:10.1016/j.ajo.2012.03.012 · Cited by 22
Retinal Microenvironment Imbalance in Dry Age-Related Macular Degeneration: A Mini-Review
Barnett, B. P., & Handa, J. T. (2013) · Gerontology · doi:10.1159/000346169 · Cited by 21
Yu, Y., Wagner, E. K., Souied, E. H., Seitsonen, S., Immonen, I. J. R., Häppölä, P., Raychaudhuri, S., Daly, M. J., & Seddon, J. M. (2016) · Human Molecular Genetics · doi:10.1093/hmg/ddw336 · Cited by 23
Fritzinger, D. C., Dean, R. R., Meschter, C. L., Wong, K., Halter, R., Borlak, J. T., John, W. S., & Vogel, C. (2010) · Advances in experimental medicine and biology · doi:10.1007/978-1-4419-5635-4_11 · Cited by 19
“2007) while others appear to be protective (Gold et al. 2006; Hageman et al. 2005).”
BackgroundGenetic Insights Into the Pathobiology of Age-related Macular Degeneration
Mullins, R. F. (2006) · International Ophthalmology Clinics · doi:10.1097/iio.0b013e31802bd3e6 · Cited by 19
Seeing the light: New insights into the molecular pathogenesis of retinal diseases
Campochiaro, P. A. (2007) · Journal of Cellular Physiology · doi:10.1002/jcp.21213 · Cited by 22
“High risk and protective variants have also been identified in other genes that code for proteins involved in the regulation of complement, complement Factor B and complement component 2 (Gold et al., 2006).”
BackgroundComplement factor H and related proteins in age-related macular degeneration
Calippe, B., Guillonneau, X., & Sennlaub, F. (2014) · Comptes Rendus. Biologies · doi:10.1016/j.crvi.2013.12.003 · Cited by 18
“Polymorphisms of several other genes in the alternative complement pathway, including CFI [52], CFB [53], and C3 [54], have also been shown to be associated with AMD and are likely to affect the alternative complement cascade independently of CFH function.”
BackgroundYang, M., Fan, J.-J., Wang, J., Zhao, Y., Teng, Y., & Liu, P. (2015) · Immunologic Research · doi:10.1007/s12026-015-8762-x · Cited by 18
“Furthermore, polymorphisms of C2 and CFB genes are also associated with multiple inflammatory diseases, such as AMD, lupus and atypical hemolytic–uremic syndrome (aHUS) [19, 22, 23].”
BackgroundLü, F., Shi, Y., Qu, C., Zhao, P., Liu, X., Gong, B., Ma, S., Zhou, Y., Zhang, Q., Fei, P., et al. (2013) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.12-11381 · Cited by 19
Crowley, M. A., Delgado, O., Will-Orrego, A., Buchanan, N. M., Anderson, K., JAFFEE, B. D., Dryja, T. P., & Liao, S.-M. (2018) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.17-22605 · Cited by 18
Chen, H., Sun, J., Zhou, B., Peng, J., Xie, Q., Liang, X., Fan, R., Conran, C., Xu, J., Ji, Y., et al. (2020) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.15624 · Cited by 18
McMahon, O., Hallam, T. M., Patel, S., Harris, C. L., Menny, A., Zelek, W. M., Widjajahakim, R., Java, A., Cox, T. E., Tzoumas, N., et al. (2021) · Human Molecular Genetics · doi:10.1093/hmg/ddab086 · Cited by 20
MITOCHONDRIAL VARIATION AND THE RISK OF AGE-RELATED MACULAR DEGENERATION ACROSS DIVERSE POPULATIONS
RESTREPO, N. A., Mitchell, S. L., Goodloe, R., Murdock, D. G., Haines, J. L., & Crawford, D. C. (2014) · Pacific Symposium on Biocomputing (PSB) · doi:10.1142/9789814644730_0024 · Cited by 18
Frederick, P. A., & Kleinman, M. E. (2014) · Current Ophthalmology Reports · doi:10.1007/s40135-013-0037-x · Cited by 20
Risk of non‐Hodgkin lymphoma in association with germline variation in complement genes
Cerhan, J. R., Novak, A. J., Fredericksen, Z. S., Wang, A. H., Liebow, M., Call, T. G., Doǧan, A., Witzig, T. E., Ansell, S. M., Habermann, T. M., et al. (2009) · British Journal of Haematology · doi:10.1111/j.1365-2141.2009.07675.x · Cited by 18
“…thought to be due to chronic inflammation from deposition of complement proteins, a common risk haplotype and two protective haplotypes have been identified based on variants in CFB (L9H, R32Q) and C2 (E318D, intron 10) (Gold et al, 2006), which was confirmed in a second study (Maller et al, 2006).”
BackgroundMa, L., Tang, S. M., Rong, S. S., Chen, H., Young, A. L., Kumaramanickavel, G., Pang, C. P., & Chen, L. J. (2015) · Scientific Reports · doi:10.1038/srep09497 · Cited by 19
Chen, Z., Zhai, Y., Zhang, W. E., Teng, Y., & Yao, K. (2015) · Medicine · doi:10.1097/md.0000000000002238 · Cited by 18
Genetic Association Analysis of Drusen Progression
Hoffman, J., van Grinsven, M. J. J. P., Li, C., Brantley, M. A., McGrath, J. A., Agarwal, A., Scott, W. K., Schwartz, S. G., Kovach, J. L., Pericak‐Vance, M. A., et al. (2016) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.15-18571 · Cited by 20
Hughes, A. E., Bridgett, S., Meng, W., Li, M., Curcio, C. A., Stambolian, D., & Bradley, D. (2016) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.15-18744 · Cited by 23
Zhang, M. X., Zhao, X. F., Ren, Y., Geng, T., Yang, H., Feng, T., Jin, T., & Chen, C. (2015) · Genetics and Molecular Research · doi:10.4238/2015.october.16.24 · Cited by 20
Occurrence of atypical HUS associated with influenza B
van Hoeve, K., Vandermeulen, C., Ranst, M. A. V., Levtchenko, E. N., van den Heuvel, L., & Mekahli, D. (2017) · European Journal of Pediatrics · doi:10.1007/s00431-017-2856-5 · Cited by 18
Annamalai, B., Parsons, N., Belhaj, M., Brandon, C. S., Potts, J. D., & Rohrer, B. (2018) · Translational Vision Science & Technology · doi:10.1167/tvst.7.2.3 · Cited by 18
(Epi)Genetic Analyses of Age-Related Macular Degeneration: Case-Control and Discordant Twin Studies
Hutchinson, J. N., Fagerness, J., Kirby, A. W., Reynolds, R. C., Zak, A., Gimelbrant, A. A., Plenge, R. M., Daly, M. J., Chess, A. J., & Seddon, J. M. (2014) · Human Heredity · doi:10.1159/000362814 · Cited by 18
Fourgeux, C., Dugas, B., Richard, F., Björkhem, I., Acar, N., Bron, A. M., Korobelnik, J., Leveziel, N., Zerbib, J., Puche, N., et al. (2012) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.12-9652 · Cited by 18
Nakata, I., Yamashiro, K., Kawaguchi, T., Nakanishi, H., Akagi-Kurashige, Y., Miyake, M., Tsujikawa, A., Yamada, R., Matsuda, F., Yoshimura, N., et al. (2015) · Scientific Reports · doi:10.1038/srep09345 · Cited by 27
Kanan, Y., Gordon, W. C., Mukherjee, P. K., Bazan, N. G., & Al‐Ubaidi, M. R. (2014) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-014-0111-4 · Cited by 18
“system activation that limits complement-induced cell injury and inflammation (Bok 2005; Gold et al. 2006).”
InfluentialMansoor, N., Wahid, F., Azam, M., Shah, K., den Hollander, A. I., Qamar, R., & Ayub, H. (2019) · Current Molecular Medicine · doi:10.2174/1566524019666190828150625 · Cited by 18
Caruso, A., Vollmer, J., Macháček, M., & Körtvely, E. (2020) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1008139 · Cited by 18
Schnabolk, G., Obert, E., Banda, N. K., & Rohrer, B. (2020) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.61.14.11 · Cited by 17
Quantitative multiplex profiling of the complement system to diagnose complement‐mediated diseases
Willems, E., Lorés‐Motta, L., Zanichelli, A., Suffritti, C., van der Flier, M., Molen, R. G. V. D., Langereis, J. D., van Drongelen, J., van den Heuvel, L. P., Volokhina, E. B., et al. (2020) · Clinical & Translational Immunology · doi:10.1002/cti2.1225 · Cited by 18
“41 Yet, in this multiplex assay we found that this variant resulted in ~ 60% of the control levels (although statistically not significant), confirming earlier larger studies.”
Pathological Effects of Mutant C1QTNF5 (S163R) Expression in Murine Retinal Pigment Epithelium
Dinculescu, A., Min, S.-H., Dyka, F. M., Deng, W., Stupay, R. M., Chiodo, V. A., Smith, W. C., & Hauswirth, W. W. (2015) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.15-17166 · Cited by 18
Liu, P., Thomson, B. R., Khalatyan, N., Feng, L., Liu, X., Savas, J. N., Quaggin, S. E., & Jin, J. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1807982115 · Cited by 17
SERPING1 polymorphisms in polypoidal choroidal vasculopathy.
Li, M., Wen, F., Zuo, C., Zhang, X., Chen, H., Huang, S., & Luo, G. (2010) · PubMed Central · Cited by 17
Age-Related Macular Degeneration
Rosenfeld, P. J., Martidis, A., & TENNANT, M. T. S. (2009) · Elsevier eBooks · doi:10.1016/b978-0-323-04332-8.00100-1 · Cited by 21
Miyake, M., Yamashiro, K., Tamura, H., Kumagai, K., Saito, M., Sugahara-Kuroda, M., Yoshikawa, M., Oishi, M., Akagi-Kurashige, Y., Nakata, I., et al. (2015) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.14-16020 · Cited by 17
Complement Factor B Mediates Ocular Angiogenesis through Regulating the VEGF Signaling Pathway
Murray, H., Qiu, B., Ho, S. Y., & Wang, X. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22179580 · Cited by 16
Xiao, J. F., Xie, B., Dao, D., Spedale, M., D’Souza, M., Theriault, B. R., Hariprasad, S. M., Sulakhe, D., Chang, E. B., & Skondra, D. (2022) · Cells · doi:10.3390/cells11132076 · Cited by 16
McCaleb, M. L., Hughes, S. G., Grossman, T. R., Frazer‐Abel, A. A., Jung, B., Yin, L., Henry, S. P., Monia, B. P., Schneider, E., Geary, R. S., et al. (2025) · Immunobiology · doi:10.1016/j.imbio.2025.152876 · Cited by 17
Complement factor B polymorphism 32W protects against age-related macular degeneration.
Hughes, A. E., Mullan, G., & Bradley, D. (2011) · PubMed Central · Cited by 21
McLure, C. A., Hinchliffe, P., Lester, S. E., Williamson, J. F., Millman, J. A., Keating, P. J., Stewart, B. J., & Dawkins, R. L. (2013) · Genomics · doi:10.1016/j.ygeno.2013.02.011 · Cited by 16
“The mechanisms responsible are multifactorial and dependent upon haplospecific interactions of coding and non-coding sequences [23, 24].”
BackgroundGuymer, R. H., Cipriani, T., Rittenhouse, K. D., Lim, L. L., Robman, L. D., Li, W., Wang, W., Deng, S., & Banerjee, P. (2015) · Graefe s Archive for Clinical and Experimental Ophthalmology · doi:10.1007/s00417-015-2970-x · Cited by 18
“C3 gene, further solidifying a role for complement in this disease [2, 6, 7] All these genes are implicated in the comple-”
BackgroundYoneyama, S., Sakurada, Y., Mabuchi, F., Sugiyama, A., Kubota, T., & Iijima, H. (2014) · Ophthalmic Genetics · doi:10.3109/13816810.2014.921313 · Cited by 17
Gupta, A., Juyal, G., Sood, A., Midha, V., Yamazaki, K., Vila, A. V., Esaki, M., Matsui, T., Takahashi, A., Kubo, M., et al. (2016) · European Journal of Human Genetics · doi:10.1038/ejhg.2016.131 · Cited by 16
Association of C-Reactive Protein Genetic Polymorphisms With Late Age-Related Macular Degeneration
Cipriani, V., Hogg, R. E., Sofat, R., Moore, A. T., Webster, A. R., Yates, J. R. W., FLETCHER, A. E., & for the European Eye (EUREYE) Study Group (2017) · JAMA Ophthalmology · doi:10.1001/jamaophthalmol.2017.2191 · Cited by 16
Yu, Q., Yao, Y., Zhu, J., Xin, B., Xie, T., Sun, C., & Cao, J. (2015) · Gene · doi:10.1016/j.gene.2015.02.039 · Cited by 18
ARMS2 interference leads to decrease of proinflammatory mediators
Zeng, F., Zhang, M., Xu, Y., & Xu, H. (2013) · Graefe s Archive for Clinical and Experimental Ophthalmology · doi:10.1007/s00417-013-2442-0 · Cited by 18
“It has been reported that serum IL-6 levels correlated with the progression of AMD, and high levels of serum IL-6 were associated with the geographic atrophy type of AMD [13, 14].”
BackgroundHanda, J. T., Tagami, M., Ebrahimi, K. B., Leibundgut, G., Janiak, A., Witztum, J. L., & Tsimikas, S. (2015) · Europe PMC (PubMed Central) · Cited by 21
Maroñas, O., García‐Quintanilla, L., Luaces-Rodríguez, A., Fernández‐Ferreiro, A., Latorre, A., Abraldes, M. J., Lamas, M. J., & Carracedo, Á. (2019) · Current Medicinal Chemistry · doi:10.2174/0929867326666190711105325 · Cited by 18
Ronan, S. M., Nusinowitz, S., Swaroop, A., & Heckenlively, J. R. (2006) · PubMed · Cited by 17
Bailey, J. N. C., Pericak‐Vance, M. A., & Haines, J. L. (2014) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a017186 · Cited by 17
“The undisputable contribution of genetic variation to AMD is supported by several lines of evidence including increased risk for AMD among relatives of patients (Klaver et al. 1998; Clemons Unknown genetic variation Hypertension Aging Diet Smoking CFH Environmental effects VEGFA TNFRSF10A TIMP3 SLC16A8 RAD51B LIPC Age…”
BackgroundInfluentialBringing the genetics of macular degeneration into focus
Haines, J. L., Spencer, K. M., & Pericak-Vance, M. A. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0708151104 · Cited by 15
Pharmacogenetics and Age-Related Macular Degeneration
Schwartz, S. G., & Brantley, M. A. (2011) · Journal of Ophthalmology · doi:10.1155/2011/252549 · Cited by 15
“Currently, there are three anti-VEGF agents in clinical use in the US: pegaptanib (Macugen, Eyetech, Palm Beach Gardens, Fla) [4], ranibizumab (Lucentis, Genentech, South San Francisco, Calif) [5, 6], and bevacizumab (Avastin, Genentech, South San Francisco, Calif) [7].”
BackgroundParekh, Z., Xiao, J. F., Mani, A., Evans, Q., Phung, C., Barba, H., Xie, B., Sidebottom, A. M., Sundararajan, A., Lin, H., et al. (2025) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.66.4.21 · Cited by 15
“57,58 For example, Zysset-Burri et al. 17 analyzed the gut microbiomes of C3-deficient and wild-type mice in terms of taxonomic and functional profiles.”
Tanaka, K., Nakayama, T., Mori, R., Sato, N., Kawamura, A., & Yuzawa, M. (2014) · BMC Ophthalmology · doi:10.1186/1471-2415-14-83 · Cited by 15
Yamashiro, K., Hosoda, Y., Miyake, M., Takahashi, A., Ooto, S., & Tsujikawa, A. (2020) · Japanese Journal of Ophthalmology · doi:10.1007/s10384-020-00773-w · Cited by 15
He, C., Li, Y., Zhang, R., Chen, J., Feng, X., & Duan, Y. (2021) · Oncology Letters · doi:10.3892/ol.2021.12739 · Cited by 16
Potential therapeutic targets for age-related macular degeneration: The nuclear option
Choudhary, M., & Malek, G. (2022) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2022.101130 · Cited by 15
“, 2019) including, complement factor B (CFB) and complement component 2 (C2) also confer increased or decreased susceptibility to AMD (Gold et al., 2006).”
BackgroundHallam, T. M., Cox, T. E., Smith‐Jackson, K., Brocklebank, V., Baral, A. J., Tzoumas, N., STEEL, D. H., Wong, E. K. S., Shuttleworth, V. G., Lotery, A. J., et al. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.1028760 · Cited by 16
“It is the components [C3 (4), factor B (FB) (5)] and regulators [Factor I (FI) (3), FactorH (FH)] (6–9) of theAP that aremost strongly linked toAMD.”
BackgroundAnimal Models for Eye Diseases and Therapeutics
Iwata, T., & Tomarev, S. I. (2008) · Humana Press eBooks · doi:10.1007/978-1-59745-285-4_31 · Cited by 16
Age-Related Macular Degeneration: A Scientometric Analysis.
Ramin, S., Soheilian, M., Habibi, G., Ghazavi, R., Gharebaghi, R., & Heidary, F. (2015) · Medical Hypothesis Discovery & Innovation in Ophthalmology · Cited by 18
No association between the T280M polymorphism of the CX3CR1 gene and exudative AMD
Zerbib, J., Puche, N., Richard, F., Leveziel, N., Cohen, S. Y., Korobelnik, J., Sahel, J., Münnich, A., Kaplan, J., Rozet, J., et al. (2011) · Experimental Eye Research · doi:10.1016/j.exer.2011.05.005 · Cited by 18
Peter, I., & Seddon, J. M. (2010) · American Journal of Ophthalmology · doi:10.1016/j.ajo.2010.06.012 · Cited by 15
Quellec, G., Russell, S. R., Scheetz, T. E., Stone, E. M., & Abràmoff, M. D. (2011) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.10-6232 · Cited by 17
Genetics of Age-Related Macular Degeneration: Update
Scholl, H. P. N., Fleckenstein, M., Issa, P. C., Keilhauer, C. N., Holz, F. G., & Weber, B. H. F. (2007) · Essentials in ophthalmology/Essentials ophthalmology · doi:10.1007/978-3-540-33672-3_3 · Cited by 15
“The finding that variants at CFH and factor B are responsible for a large fraction of AMD cases (at least in Caucasians) suggests the importance of the alternative complement pathway in the pathobiology of AMD and further strengthens the notion that inflammation plays a major role in this common disease [ 24 ].”
BackgroundInfluentialInvestigation of genetic base in the treatment of age-related macular degeneration
Gourgouli, K., Gourgouli, I., Tsaousis, G., Spai, S., Νισκοπούλου, Μ., Efthimiopoulos, S., & Lamnissou, K. (2020) · International Ophthalmology · doi:10.1007/s10792-019-01274-7 · Cited by 17
Complement Inhibition for Geographic Atrophy: A Tempting Target with Mixed Results
Lin, J. B., Halawa, O. A., Miller, J. W., & Vavvas, D. G. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10132890 · Cited by 16
Vienne-Jumeau, A., Bousquet, E., & Béhar‐Cohen, F. (2025) · Current Opinion in Immunology · doi:10.1016/j.coi.2025.102616 · Cited by 14
“The aggregation of histological, genetic, and clinical data indicates that chronic, complement overactivation plays a pivotal role in disease onset, and its contribution to disease progression is the subject of active investigation [8,9].”
The association between macular pigment optical density and CFH, ARMS2, C2/BF, and C3 genotype
Loane, E., Nolan, J. M., McKay, G. J., & Beatty, S. (2011) · Experimental Eye Research · doi:10.1016/j.exer.2011.07.005 · Cited by 16
“The role of the complement system was further emphasized with the discovery of amended risk of AMD associated with the paralogous complement component 2 (C2) and complement factor B (BF) genes, and the complement component 3 (C3) gene (Gold et al., 2006; Maller et al., 2007; Yates et al., 2007).”
BackgroundGenetic analysis of simultaneous geographic atrophy and choroidal neovascularization
Grob, S., Luo, J., Hughes, G., Lee, C., Zhou, X., Lee, J., Du, H., Ferreyra, H. A., Freeman, W. R., Kozak, I., et al. (2012) · Eye · doi:10.1038/eye.2012.107 · Cited by 14
Metadata
- Authors
- The AMD Genetics Clinical Study Group, Gold, B., Merriam, J. E., Zernant, J., Hancox, L. S., Taiber, A. J., Gehrs, K., Cramer, K., Neel, J., Bergeron, J., Barile, G. R., Smith, R. T., Hageman, G. S., Dean, M., & Allikmets, R.
- Affiliations
- National Cancer Institute (US)
- Columbia University (US)
- University of Iowa (US)
- Science Applications International Corporation (United States) (US)
- Corresponding author
- Dean, Michael
- Allikmets, Rando
- ORCID
- Venue
- Nature Genetics
- Published
- 2006-03-05
- Volume
- 38
- Issue
- 4
- Pages
- 458-462
- ISSN
- 1061-4036 (ISSN-L)
- 1546-1718
- PMC
- PMC2921703
- OpenAlex
- W1997288094
- Cited by
- 1,075
- References
- 31
- Citations by year
- 2026: 17 · 2025: 17 · 2024: 18 · 2023: 17 · 2022: 27 · 2021: 40 · 2020: 33 · 2019: 28 · 2018: 27 · 2017: 31 · 2016: 47 · 2015: 65 · 2014: 74 · 2013: 69 · 2012: 90
- FWCI
- 85.56
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Genetics (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institutes of Health
- National Eye Institute (EY11515, R01EY013435, EY-13435, R01EY015520, R01EY011515)
- National Cancer Institute (N01-CO-124000)
- Topics
- Health Sciences › Medicine › Ophthalmology › Retinal Diseases and Treatments
- Life Sciences › Immunology and Microbiology › Immunology › Complement system in diseases
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic Associations and Epidemiology
- Keywords
- age-related macular degeneration, factor B, alternative complement pathway, genetic risk variants, haplotypes, complement factor H, MHC class III, genetic susceptibility
- MeSH terms
- Aged, Aged, 80 and over, Aging, Chromatography, High Pressure Liquid, Complement C2, Haplotypes, Humans, Immunohistochemistry, Macular Degeneration, Molecular Sequence Data, Complement Factor B, Cohort Studies, Case-Control Studies
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.